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Research
fertilisation (IVF) or surgical reanastomosis
of the fallopian tubes. There are many finan-
cial and clinical implications in the choice of
treatment, particularly for women aged 40
years and older. Human fertility decreases
markedly at the end of reproductive life,








Objective:  To determine the live birth rate following surgical reversal of sterilisation 
in women aged 40 years and older.
Design:  Retrospective cohort study of pregnancy outcome following day surgery 
microsurgical reversal of sterilisation performed by two reproductive microsurgeons 
in the private sector.
ng and patients:  47 patients (aged 40 years or older) who had reversal of 
isation performed between 1997 and 2005 in Adelaide, South Australia (n = 35), 
e Infertility Centre of St Louis, Missouri, USA (n = 12).
 outcome measures:  Independently audited live birth surviving the neonatal 
d.
lts:  Of the 47 patients on whom follow-up was obtainable from the two centres, 
0%) had a live birth, 7 had had only a first trimester miscarriage at the time of follow-
up, and 21 (44%) had failed to conceive. Age at conception ranged between 40 and 47 
years. Two women had two live births following surgery. The total direct costs (Australian 
dollars, adjusted to 2005) in Australia were $4850 per treatment, and $11 317 per live 
birth. The corresponding direct cost of a single cycle of in-vitro fertilisation (IVF) in 
Australia has been estimated at $6940, with a cost per live birth of $97 884 for women 
aged 40–42 years and $182 794 for older women.
Conclusion:  Previously sterilised women wanting further pregnancy should be offered 
tubal surgery as an alternative to IVF, as it offers them the opportunity to have an entirely 
natural pregnancy. In settings where IVF is financially supported by government 
agencies or insurance, tubal reversal is a highly cost-effective strategy for the previously 
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fertile woman.ter
the
famS ilisation is common in Australia and United States, usually chosen atily completion. Requests for
renewed fertility arise because of a new
partner, improved economic circumstances
or, more rarely, death of a child. Current
options for renewed fertility include in-vitro
after age 40 years, particularly in sub-fertile
women. Possibly for this reason, the Ameri-
can Fertility Society recommends that
women older than 40 years have IVF and
not undergo reversal of sterilisation.1
In Australia, the live birth rate following IVF
treatment is 5% for women aged 40–42 years
and 2% for older women.2,3 IVF requires
intensive treatment by a team of doctors,
nurses and counsellors, with each repeat fresh
or frozen embryo thaw cycle incurring addi-
tional emotional and financial costs. The use
of assisted reproductive technology has caused
a significant increase in high-risk multiple
pregnancies across all ages, which has given
impetus for single embryo transfers, with sub-
sequent increase in the number of treatment
cycles to achieve success.
For women choosing tubal reanastomosis,
markedly different financial circumstances
apply. In Australia since 1997, when Medi-
care payment for reversal of sterilisation was
withdrawn, the choice has been to self-fund
a reversal operation or to undergo Medicare-
funded and “safety net”-supported IVF treat-
ment, for which most of the cost is reim-
bursed in second and subsequent IVF
treatments in the same calendar year. Tubal
reanastomosis requires a general anaesthetic
and day surgery admission, but offers the
prospect of spontaneous pregnancy with a
natural background rate of multiple preg-
nancy of less than 2% and the opportunity
to have more than one child before recon-
sidering contraceptive options. However,
the most important difference is the restored
capacity for conception with each ovulatory
cycle, which may provide an explanation for
conception in older women when gonado-
trophin-stimulated oocyte development, fer-
tilisation and implantation seem to be no
longer successful.
The main factors influencing success fol-
lowing reanastomosis are the site of anasto-
mosis,4-6 length of residual fallopian tube,
and the surgical technique.7 For the most
commonly encountered Filshie or Hulka
Clip and Falope-Ring type of sterilisation,
microsurgery offers a very high chance of
tubal patency and fertility. Live birth rates of
80%–90% are achievable in women younger
than 40 years,8-12 with poorer outcomes in
women aged 40 years or older.13-16
Our aim in this retrospective cohort study
was to assess whether tubal microsurgery in
women aged 40 years and older is a viable
alternative to IVF treatment.
METHOD
Study population
Consenting women aged 40 years or older
who had tubal reanastomosis between 1997
and 2005 by two microsurgeons (O M P in
Australia and S J S in the United States) were
asked to provide details of subsequent preg-
nancies, by postal questionnaire or phone
consultation.
All women in the final dataset had either
been pregnant or had at least 12 months’
exposure to conception after reversal of
sterilisation.
Surgical technique
The methods of sterilisation were tubal clips
(70%), Falope-Ring (23%) and Pomeroy
tubal ligation (7%). The reversal procedure
involved a 3–5 cm suprapubic incision, into
which the uterine fundus and fallopian
tubes were manipulated via a transcervical
uterine cannula. A two-layer 8-0 nylon
microsurgical anastomosis was performed
on the exposed new tubal ends. Magnifica-
tion (10–25) was provided by an OPMI5
Zeiss operating microscope, and tubal pat-
ency was confirmed following anastomosis
by transcervical instillation of dilute methyl-JA • Volume 187 Number 5 • 3 September 2007 271
R ESEARCHene blue dye. Reconstituted tubal lengths
were greater than 4 cm in all cases, and the
anastomoses were isthmic (85%), tubocor-
nual (5%) and isthmic ampullary (10%).
Patients were discharged from hospital
within 24 hours of admission.
Ethics approval
The Australian study received ethics
approval from the University of Adelaide
Ethics Committee. Another 12 patients who
were not part of the ethics-approved study
but who fulfilled all criteria were provided
by S J S of St Louis, Missouri, US.
RESULTS
Of the 47 eligible patients in the Australian
group, three could not be found and seven
refused enrolment. Two consenting women
were excluded as they were using contracep-
tion and not attempting to conceive because
of an intercurrent illness. Live births and
women’s ages at conception are shown in
the Box. Of the 35 Australian women, 20
had been pregnant, although six of these
had miscarriages. There were 15 live births
(two for one couple). In the St Louis group,
six of the 12 women had been pregnant and
five had six live births. Overall, 19 of the 47
women had at least one live birth (40%),
with six conceptions occurring in women
aged 44 years or older and conception
reported up to age 47 years. Time to con-
ception ranged from 4 weeks to 4 years. No
significant surgical complications occurred
and no ectopic pregnancies were reported.
The average monetary cost (Australian
dollars, adjusted to 2005) to women having
this procedure in the private sector in Aus-
tralia was $4850, and the cost per live birth
was $11 317. This compares very favourably
with IVF, where the average cost per cycle in
Australia in 2002 was $6940, and the cost
per live birth was $97 884 for women aged
40–42 years and $182 794 for women aged
42 years or older.3 Similar ratios of cost-
effectiveness of tubal reversal compared
with IVF apply in the US.
DISCUSSION
In this study, the reversal group had all been
previously fertile, making direct comparison
of success rates for women having IVF not
possible, as couples having IVF have multi-
factorial reasons for accessing treatment,
including male-factor infertility. However,
our observation that reversal of sterilisation
provides a good prospect for fertility indi-
cates that conception is more likely to occur
in natural ovulatory cycles than in stimu-
lated IVF cycles. It may be significant that
six live births in the study group occurred in
women aged 44 years or older, an age when
the likelihood of live birth from IVF is
extremely low. Additional evidence for natu-
ral fertility in older women is seen in a study
of reversal of vasectomy, in which 61% of
female partners older than 40 years con-
ceived.17
A number of publications and editorials
have addressed the issue of fertility and
ageing. Discussion largely focuses on age-
related increase in meiotic non-disjunction,
leading to chromosomal aneuploidy, low
implantation rates, and a high rate of early
pregnancy loss.18-23 In view of the compari-
son of cost per live birth, we believe Medi-
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